$2.5T
Total marketcap
$201.89B
Total volume
BTC 50.11%     ETH 15.71%
Dominance

CureVac CVAC Stock

3.21 USD {{ price }} -2.727270% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
718.8M USD
LOW - HIGH [24H]
3.19 - 3.3 USD
VOLUME [24H]
648.75K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.6 USD

CureVac Price Chart

CureVac CVAC Financial and Trading Overview

CureVac stock price 3.21 USD
Previous Close 10.17 USD
Open 10.11 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 9.87 - 10.26 USD
52 Week Range 5.63 - 15.62 USD
Volume 250.32K USD
Avg. Volume 497.11K USD
Market Cap 2.23B USD
Beta (5Y Monthly) 2.869236
PE Ratio (TTM) N/A
EPS (TTM) -1.6 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 15.98 USD

CVAC Valuation Measures

Enterprise Value 1.7B USD
Trailing P/E N/A
Forward P/E -13.253333
PEG Ratio (5 yr expected) -1.11
Price/Sales (ttm) 44.34568
Price/Book (mrq) 3.1189206
Enterprise Value/Revenue 33.878
Enterprise Value/EBITDA -7.509

Trading Information

CureVac Stock Price History

Beta (5Y Monthly) 2.869236
52-Week Change -30.34%
S&P500 52-Week Change 20.43%
52 Week High 15.62 USD
52 Week Low 5.63 USD
50-Day Moving Average 8.57 USD
200-Day Moving Average 8.28 USD

CVAC Share Statistics

Avg. Volume (3 month) 497.11K USD
Avg. Daily Volume (10-Days) 406.02K USD
Shares Outstanding 223.85M
Float 122.9M
Short Ratio 6.51
% Held by Insiders 45.44%
% Held by Institutions 24.43%
Shares Short 4.2M
Short % of Float 10.58%
Short % of Shares Outstanding 1.87%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -478.10%
Gross Margin -183.74%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -14.99%
Return on Equity (ttm) -41.97%

Income Statement

Revenue (ttm) 50.18M USD
Revenue Per Share (ttm) 0.26 USD
Quarterly Revenue Growth (yoy) -70.79%
Gross Profit (ttm) -91549000 USD
EBITDA -226372992 USD
Net Income Avi to Common (ttm) -291355008 USD
Diluted EPS (ttm) -1.71
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 617.52M USD
Total Cash Per Share (mrq) 2.76 USD
Total Debt (mrq) 41.15M USD
Total Debt/Equity (mrq) 5.77 USD
Current Ratio (mrq) 7.607
Book Value Per Share (mrq) 3.187

Cash Flow Statement

Operating Cash Flow (ttm) -249252000 USD
Levered Free Cash Flow (ttm) -298620256 USD

Profile of CureVac

Country United States
State N/A
City Tübingen
Address Friedrich-Miescher-Strasse 15
ZIP 72076
Phone 49 7071 9883 0
Website https://www.curevac.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 904

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer therapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

Q&A For CureVac Stock

What is a current CVAC stock price?

CureVac CVAC stock price today per share is 3.21 USD.

How to purchase CureVac stock?

You can buy CVAC shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for CureVac?

The stock symbol or ticker of CureVac is CVAC.

Which industry does the CureVac company belong to?

The CureVac industry is Biotechnology.

How many shares does CureVac have in circulation?

The max supply of CureVac shares is 223.92M.

What is CureVac Price to Earnings Ratio (PE Ratio)?

CureVac PE Ratio is now.

What was CureVac earnings per share over the trailing 12 months (TTM)?

CureVac EPS is -1.6 USD over the trailing 12 months.

Which sector does the CureVac company belong to?

The CureVac sector is Healthcare.

CureVac CVAC included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Global Market Composite NQGM 2185.85 USD
-0.31
2177.48 USD 2204.21 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD